Walleye Trading’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-119,362
Closed -$150K 4871
2023
Q1
$150K Buy
+119,362
New +$228K ﹤0.01% 3678
2022
Q4
Sell
-1,824
Closed -$22K 5125
2022
Q3
$22K Sell
1,824
-2,077
-53% -$25.8K ﹤0.01% 4411
2022
Q2
$33K Buy
+3,901
New +$30.2K ﹤0.01% 4432
2022
Q1
Sell
-7,282
Closed -$82K 5526
2021
Q4
$82K Buy
+7,282
New +$86.5K ﹤0.01% 4479
2021
Q2
Sell
-11,273
Closed -$104K 5308
2021
Q1
$104K Buy
+11,273
New +$114K ﹤0.01% 4071

Other funds holding GOSS

Walleye Trading's GOSS Position: Q2 2023 in Review

Walleye Trading sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 119,362 shares — an estimated $150K sold.

Walleye Trading first reported a position in GOSS in Q1 2021 and held it in 5 quarters. The position peaked at $150K in Q1 2023. 99 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • Walleye Trading reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 119,362 Gossamer Bio shares in Q2 2023, an estimated $150K.
  • Walleye Trading first reported a position in Gossamer Bio in Q1 2021 and held it in 5 quarters.
  • Walleye Trading's Gossamer Bio position peaked at $150K in Q1 2023.
  • 99 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.